220 related articles for article (PubMed ID: 20557304)
1. A novel function of microRNA let-7d in regulation of galectin-3 expression in attention deficit hyperactivity disorder rat brain.
Wu L; Zhao Q; Zhu X; Peng M; Jia C; Wu W; Zheng J; Wu XZ
Brain Pathol; 2010 Nov; 20(6):1042-54. PubMed ID: 20557304
[TBL] [Abstract][Full Text] [Related]
2. Circulating MicroRNA Let-7d in Attention-Deficit/Hyperactivity Disorder.
Wu LH; Peng M; Yu M; Zhao QL; Li C; Jin YT; Jiang Y; Chen ZY; Deng NH; Sun H; Wu XZ
Neuromolecular Med; 2015 Jun; 17(2):137-46. PubMed ID: 25724585
[TBL] [Abstract][Full Text] [Related]
3. Theobromine improves hyperactivity, inattention, and working memory
Matsuzaki K; Sugimoto N; Hossain S; Islam R; Sumiyoshi E; Hashimoto M; Kishi H; Shido O
Food Funct; 2024 May; 15(10):5579-5595. PubMed ID: 38713055
[TBL] [Abstract][Full Text] [Related]
4. Transcriptional profiling of SHR/NCrl prefrontal cortex shows hyperactivity-associated genes responsive to amphetamine challenge.
Dela Peña IJI; Dela Peña I; de la Peña JB; Kim HJ; Sohn A; Shin CY; Han DH; Kim BN; Ryu JH; Cheong JH
Genes Brain Behav; 2017 Sep; 16(7):664-674. PubMed ID: 28422445
[TBL] [Abstract][Full Text] [Related]
5. Prefrontal cortex Homer expression in an animal model of attention-deficit/hyperactivity disorder.
Hong Q; Zhang M; Pan XQ; Guo M; Li F; Tong ML; Chen RH; Guo XR; Chi X
J Neurol Sci; 2009 Dec; 287(1-2):205-11. PubMed ID: 19709672
[TBL] [Abstract][Full Text] [Related]
6. Nr3C1-Bhlhb2 Axis Dysregulation Is Involved in the Development of Attention Deficit Hyperactivity.
Wu LH; Cheng W; Yu M; He BM; Sun H; Chen Q; Dong YW; Shao XT; Cai QQ; Peng M; Wu XZ
Mol Neurobiol; 2017 Mar; 54(2):1196-1212. PubMed ID: 26820676
[TBL] [Abstract][Full Text] [Related]
7. The usefulness of the spontaneously hypertensive rat to model attention-deficit/hyperactivity disorder (ADHD) may be explained by the differential expression of dopamine-related genes in the brain.
Li Q; Lu G; Antonio GE; Mak YT; Rudd JA; Fan M; Yew DT
Neurochem Int; 2007 May; 50(6):848-57. PubMed ID: 17395336
[TBL] [Abstract][Full Text] [Related]
8. Droxidopa alters dopamine neuron and prefrontal cortex activity and improves attention-deficit/hyperactivity disorder-like behaviors in rats.
Dela Peña I; Shen G; Shi WX
Eur J Pharmacol; 2021 Feb; 892():173826. PubMed ID: 33347825
[TBL] [Abstract][Full Text] [Related]
9. Common prefrontal cortical gene expression profiles between adolescent SHR/NCrl and WKY/NCrl rats which showed inattention behavior.
Dela Peña I; Bang M; Lee J; de la Peña JB; Kim BN; Han DH; Noh M; Shin CY; Cheong JH
Behav Brain Res; 2015 Sep; 291():268-276. PubMed ID: 26048425
[TBL] [Abstract][Full Text] [Related]
10. Metabolomics study of the prefrontal cortex in a rat model of attention deficit hyperactivity disorder reveals the association between cholesterol metabolism disorder and hyperactive behavior.
Chen T; Yuan H; Sun YB; Song YC; Lu M; Ni X; Han X
Biochem Biophys Res Commun; 2020 Mar; 523(2):315-321. PubMed ID: 31864712
[TBL] [Abstract][Full Text] [Related]
11. Clozapine decreases exploratory activity and increases anxiety-like behaviour in the Wistar-Kyoto rat but not the spontaneously hypertensive rat model of attention-deficit/hyperactivity disorder.
Mc Fie S; Sterley TL; Howells FM; Russell VA
Brain Res; 2012 Jul; 1467():91-103. PubMed ID: 22658977
[TBL] [Abstract][Full Text] [Related]
12. Gene expression of synaptosomal-associated protein 25 (SNAP-25) in the prefrontal cortex of the spontaneously hypertensive rat (SHR).
Li Q; Wong JH; Lu G; Antonio GE; Yeung DK; Ng TB; Forster LE; Yew DT
Biochim Biophys Acta; 2009 Aug; 1792(8):766-76. PubMed ID: 19482079
[TBL] [Abstract][Full Text] [Related]
13. Altered dopaminergic function in the prefrontal cortex, nucleus accumbens and caudate-putamen of an animal model of attention-deficit hyperactivity disorder--the spontaneously hypertensive rat.
Russell V; de Villiers A; Sagvolden T; Lamm M; Taljaard J
Brain Res; 1995 Apr; 676(2):343-51. PubMed ID: 7614004
[TBL] [Abstract][Full Text] [Related]
14. Baicalin regulates the dopamine system to control the core symptoms of ADHD.
Zhou R; Wang J; Han X; Ma B; Yuan H; Song Y
Mol Brain; 2019 Feb; 12(1):11. PubMed ID: 30736828
[TBL] [Abstract][Full Text] [Related]
15. Increased noradrenergic activity in prefrontal cortex slices of an animal model for attention-deficit hyperactivity disorder--the spontaneously hypertensive rat.
Russell V; Allie S; Wiggins T
Behav Brain Res; 2000 Dec; 117(1-2):69-74. PubMed ID: 11099759
[TBL] [Abstract][Full Text] [Related]
16. Distinct long non-coding RNA and mRNA expression profiles in the hippocampus of an attention deficit hyperactivity disorder model in spontaneously hypertensive rats and control wistar Kyoto rats.
Zhang S; You L; Xu Q; Ou J; Wu D; Yuan X; Liu Z; Hong Q; Tong M; Yang L; Chi X
Brain Res Bull; 2020 Aug; 161():177-196. PubMed ID: 32344128
[TBL] [Abstract][Full Text] [Related]
17. Rearing in an enriched environment attenuated hyperactivity and inattention in the Spontaneously Hypertensive Rats, an animal model of Attention-Deficit Hyperactivity Disorder.
Botanas CJ; Lee H; de la Peña JB; Dela Peña IJ; Woo T; Kim HJ; Han DH; Kim BN; Cheong JH
Physiol Behav; 2016 Mar; 155():30-7. PubMed ID: 26656767
[TBL] [Abstract][Full Text] [Related]
18. NMDA receptor function in the prefrontal cortex of a rat model for attention-deficit hyperactivity disorder.
Lehohla M; Kellaway L; Russell VA
Metab Brain Dis; 2004 Jun; 19(1-2):35-42. PubMed ID: 15214504
[TBL] [Abstract][Full Text] [Related]
19. Aberrant glutamate signaling in the prefrontal cortex and striatum of the spontaneously hypertensive rat model of attention-deficit/hyperactivity disorder.
Miller EM; Pomerleau F; Huettl P; Gerhardt GA; Glaser PE
Psychopharmacology (Berl); 2014 Aug; 231(15):3019-29. PubMed ID: 24682500
[TBL] [Abstract][Full Text] [Related]
20. Effect of catalpol on behavior and neurodevelopment in an ADHD rat model.
Yuan H; Ni X; Zheng M; Han X; Song Y; Yu M
Biomed Pharmacother; 2019 Oct; 118():109033. PubMed ID: 31545235
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
